Basilea Pharmaceutica AG (SWX:BSLN)
Switzerland · Delayed Price · Currency is CHF 54.00
-0.90 (-1.64%)
Jan 30, 2026, 5:30 PM CET
Basilea Pharmaceutica AG Market Cap
Basilea Pharmaceutica AG has a market cap or net worth of 663.56 million as of January 30, 2026. Its market cap has increased by 34.67% in one year.
Market Cap
663.56M
Enterprise Value
631.98M
Revenue
236.21M
Ranking
n/a
PE Ratio
9.87
Stock Price
54.00
Market Cap Chart
Since March 25, 2004, Basilea Pharmaceutica AG's market cap has increased from 533.29M to 663.56M, an increase of 24.43%. That is a compound annual growth rate of 1.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 663.56M | -1.28% |
| Dec 30, 2025 | 672.13M | 34.10% |
| Dec 30, 2024 | 501.21M | 18.52% |
| Dec 29, 2023 | 422.90M | -22.52% |
| Dec 30, 2022 | 545.84M | 12.62% |
| Dec 30, 2021 | 484.67M | -15.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Idorsia | 916.44M |
| Newron Pharmaceuticals | 389.88M |
| Santhera Pharmaceuticals Holding AG | 175.98M |
| BioVersys AG | 140.94M |
| Xlife Sciences AG | 127.46M |
| Molecular Partners AG | 120.61M |
| EvoNext Holdings | 6.20M |
| Addex Therapeutics | 5.83M |